| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Oric Pharmaceuticals, Inc.'s insiders have reduced their positions by a net 111,700 shares worth roughly $1.5M. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 581.7K | $5.58M | - | |
| Dir | 241.8K | $2.32M | - | |
| Dir | 84.2K | $807.5K | - | |
| CFO | 69.8K | $669.7K | -14,000 | |
| Other | 68.1K | $653.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2023 | Jacob Chacko77 | President and CEO | Sell | 15,664 | $8.01 | $125,499.35 | -2.0% | -22.2% | +17.7% | |
| Jul 5, 2023 | Jacob Chacko77 | President and CEO | Sell | 4,336 | $8.01 | $34,710.55 | -0.5% | -28.6% | -1.8% | |
| Jun 26, 2023 | Jacob Chacko77 | President and CEO | Sell | 20,000 | $8.03 | $160,562.00 | -2.4% | -8.8% | -18.7% | |
| Dec 15, 2022 | Pratik S Multani | Chief Medical Officer | Sale+OE | 2,089 | $3.25 | $6,789.25 | -22.0% | +33.2% | +186.5% | |
| Dec 15, 2022 | Dominic Piscitelli64 | Chief Financial Officer | Sale+OE | 2,089 | $3.25 | $6,789.25 | -3.0% | +33.2% | +186.5% | |
| Dec 15, 2022 | Jacob Chacko77 | President and CEO | Sale+OE | 5,764 | $3.25 | $18,733.00 | -0.7% | +33.2% | +186.5% | |
| May 13, 2022 | Jacob Chacko77 | President and CEO | Buy | 450,000 | $2.86 | $1,288,597.14 | +127.6% | +64.8% | +82.0% | |
| Mar 31, 2022 | Dominic Piscitelli64 | Chief Financial Officer | Buy | 60,000 | $5.36 | $321,624.00 | New | -15.7% | +6.7% | |
| Mar 25, 2022 | Jacob Chacko77 | President and CEO | Buy | 350,000 | $4.92 | $1,723,707.92 | +13,198% | -2.4% | +15.9% | |
| Sep 15, 2021 | Richard A. Heyman73 | Director | Sell | 1,388 | $25.04 | $34,759.74 | -0.6% | -52.1% | -86.6% |